DUAL RELEASE FORMULATION COMPRISING LEVODOPA ETHYL ESTER AND A DECARBOXYLASE INHIBITOR IN IMMEDIATE RELEASE LAYER WITH LEVODOPA ETHYL ESTER AND A DECARBOXYLASE INHIBITOR IN A CONTROLLED RELEASE CORE

Details for Australian Patent Application No. 2002322468 (hide)

Owner TEVA PHARMACEUTICAL INDUSTRIES, LTD.

Inventors LICHT, Daniela; PATASHNIK, Shulamit; NAFTALI, Ezmira; SAYAG, Naim; GILBERT, Adrian; COHEN, Sasson; ZOLLMANN, Corinne

Pub. Number AU-A-2002322468

PCT Number PCT/US02/22206

PCT Pub. Number WO2003/005967

Priority 60/305,179 12.07.01 US; 60/346,744 07.01.02 US

Filing date 12 July 2002

Wipo publication date 29 January 2003

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/305,179 12.07.01 US; 60/346,744 07.01.02 US

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002322468

8 April 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322469-Nuclear fertility restorer genes and methods of use in plants

2002322467-VOLTAGE LIMITING PROTECTION FOR HIGH FREQUENCY POWER DEVICE